Work Packages

  • WP1
    To identify the molecular, cellular and pathophysiological mechanisms leading to resistance to anti-inflammatory treatments in patients, and the mechanisms involved in the development of resistance in the pathogen.
  • WP2
    A holistic approach to analysing the complex interactions between inflammation, infection and treatments, and the mechanisms involved in the development of complications across all major systems.
  • WP3
    To identify vulnerability factors as aggravating factors in inflammatory and infectious diseases, and the mechanisms involved.
  • WP4
    To develop innovative and personalised preventive, diagnostic and therapeutic solutions for patients who are resistant to treatment or who experience complications.
  • WP5
    To assess the impact on quality of life and the socio-economic cost of treatment resistance and associated complications, as well as the benefits of personalised medicine.